Described herein are pharmaceutical packaging methods which avoid oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-sensitive medicines, these kinds of programs which include a syringe with an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with pretty lower permeability to oxygen and